On December 9th, members of the 1st IMPACT Cohort joined the M2D2 team for a night of networking with key leaders in the Massachusetts healthcare innovation ecosystem. During this in-person event, IMPACT startups shared lightning pitches of their innovations and met with partners and sponsors of M2D2.Continue reading
10 startups have been selected to participate in the first cohort of the IMPACT Accelerator Program.
This week, M2D2 announced the finalists for its IMPACT Accelerator Program, a recently launched 12-week program designed to help early-stage companies advance their innovation. These 10 finalists will work closely with M2D2 and its network of experts, receiving 1-on-1 mentorship, education workshops, and access to lab equipment. After the 12-week program, the startups will be part of a public pitch event, where other life sciences startups and investors can learn more about their innovation.Continue reading
Tyrpak will be a featured speaker and panelist as part of the UMass M2D2 “Key Considerations & Best Practices” session on June 15.
BUFFALO, N.Y., June 11, 2021 –Stephen Tyrpak, director of clinical & regulatory affairs at Garwood Medical Devices, LLC, will be a featured speaker and panelist at a June 15 virtual event being coordinated by the Massachusetts Medical Device Center (M2D2) at UMass Lowell and sponsored by Johnson & Johnson Innovation – JLABS.
Tyrpak will share his expertise and insights regarding key considerations and best practices related to regulatory strategy in and out of the U.S., the importance of reimbursement considerations early on, and clinical study design and management for early-stage companies seeking regulatory approval. He is one of five participants in the third and final program in the M2D2 Clinical Trial Series.Continue reading
While we couldn’t safely gather in Boston at Mintz headquarters, this year’s $200K Challenge proved the pandemic couldn’t slow down the innovative minds of startups around the globe. Entrepreneurs, investors, researchers academics and insiders came together after work Wednesday, April 7th for the 2021 $200K Challenge Awards Celebration.Continue reading
15 finalists have been selected from more than 170 applicants for the 10th Annual M2D2 $200K Challenge.
LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 10th annual $200K Challenge after reviewing the 170+ applications.Continue reading
Nesa Medtech is transforming women’s health by developing novel minimally invasive, safe, effective, and uterus-preserving technology to treat uterine fibroids. We talked with their Founder & CEO, Sreekar Kothamachu to learn about their journey.Continue reading
With less than a week until the International MedTech Challenge, we’d like to introduce you to another unique Finalist from India. Mimyk is building Robotics and AI technologies in endoscopy to enable clinical access to early diagnosis and treatment of GI cancers. We talked to Co-Founder Shanthanu Chakravarthy about the story behind their innovation.Continue reading
The pandemic kept us from gathering, networking, and toasting at the Boston headquarters of Mintz as we have in previous years. But more than 200 entrepreneurs, investors, researchers, academics, and insiders gathered virtually after work on Thursday, October 1 for the 2020 M2D2 $200K Challenge Awards Celebration.Continue reading
With our first-ever International MedTech Forum right around the corner, we are thrilled to introduce you CyGenica. They are one of the 6 unique Indian life sciences startups pitching their innovations on Thursday, October 8th.Continue reading